Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Leila Bengrine"'
Autor:
Isabelle L. Ray-Coquard, Aude-Marie Savoye, Camille Schiffler, Marie-Ange Mouret-Reynier, Olfa Derbel, Elsa Kalbacher, Marianne LeHeurteur, Alejandra Martinez, Corina Cornila, Mathilde Martinez, Leila Bengrine Lefevre, Frank Priou, Nicolas Cloarec, Laurence Venat, Frédéric Selle, Dominique Berton, Olivier Collard, Elodie Coquan, Olivia Le Saux, Isabelle Treilleux, Sophie Gouerant, Antoine Angelergues, Florence Joly, Olivier Tredan
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract This open-label, non-comparative, 2:1 randomized, phase II trial (NCT03275506) in women with stage IIIC/IV high-grade serous carcinoma (HGSC) for whom upfront complete resection was unachievable assessed whether adding pembrolizumab (200 mg
Externí odkaz:
https://doaj.org/article/caaac1537e0d490584c256cc9feb5b61
Autor:
Nicolas Roussot, Julie Vincent, Remi Palmier, Guillaume Constantin, Leila Bengrine, Jean-David Fumet, François Ghiringhelli
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundAdvanced biliary tract cancer (BTC) has a poor prognosis. Gemcitabine with platinum chemotherapy was the standard first-line chemotherapeutic regimen until the recent addition of anti-PD-1/PD-L1 antibodies. After disease progression, the on
Externí odkaz:
https://doaj.org/article/70a73c8ebef54d368e02047552f9e26f
Autor:
Frédérique Rousseau, Florence Ranchon, Christophe Bardin, Naoual Bakrin, Vincent Lavoué, Leila Bengrine-Lefevre, Claire Falandry
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
In recent years, major advances have been made toward the individualization of epithelial ovarian cancer care, leading to an overall improvement of patient outcomes. However, real-life data indicate that the oldest populations do not benefit from thi
Externí odkaz:
https://doaj.org/article/b7b6a5c2e1af418599171b1b3cb34f98
Autor:
Lydia Guittet, Valérie Quipourt, Thomas Aparicio, Elisabeth Carola, Jean-François Seitz, Elena Paillaud, Astrid Lievre, Rabia Boulahssass, Carole Vitellius, Leila Bengrine, Florence Canoui-Poitrine, Sylvain Manfredi
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background We have done a systematic literature review about CRC Screening over 75 years old in order to update knowledge and make recommendations. Methods PUBMED database was searched in October 2021 for articles published on CRC screening
Externí odkaz:
https://doaj.org/article/567242beefa74003ac6f21e25b61bbd1
Autor:
Katia Mahiou, Laura Vincent, Karine Peignaux‐Casasnovas, Hélène Costaz, Marie‐Martine Padeano, Alix Amet, Sandrine Dabakuyo, Ariane Mamguem Kamga, Leila Bengrine‐Lefevre, Charles Coutant
Publikováno v:
Cancer Reports, Vol 6, Iss 5, Pp n/a-n/a (2023)
Abstract Background and Objectives There is no international consensus for management of early‐stage cervical cancer (ESCC). This study aimed to retrospectively investigate disease‐free survival (DFS) and overall survival (OS) in patients with ES
Externí odkaz:
https://doaj.org/article/56ee345674de41b2a6b7f1e234bda795
Autor:
Ariane Mamguem Kamga, Leila Bengrine-Lefevre, Valérie Quipourt, Laure Favier, Ariane Darut-Jouve, Sophie Marilier, Patrick Arveux, Isabelle Desmoulins, Tienhan Sandrine Dabakuyo-Yonli
Publikováno v:
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-11 (2021)
Abstract Background With the growing number of older endometrial cancer (EC) and ovarian cancer (OC) survivors, data on long-term health-related quality of life (HRQoL) became an important issue in the management of older patients. So, the aim of thi
Externí odkaz:
https://doaj.org/article/970e40a01fbb4ae1a6dd11eb9bef4010
Autor:
Fanny Ledys, Quentin Klopfenstein, Caroline Truntzer, Laurent Arnould, Julie Vincent, Leila Bengrine, Romain Remark, Romain Boidot, Sylvain Ladoire, Francois Ghiringhelli, Valentin Derangere
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-14 (2018)
Abstract Background T lymphocytes and HLA expression on tumor cell both influence prognostic of localized colorectal cancer, but their role following chemotherapy in patients with liver metastatic colorectal cancer (mCRC) was not addressed. Methods O
Externí odkaz:
https://doaj.org/article/f4b2d253e348427284501126f50ab4c2
Publikováno v:
Cancers, Vol 14, Iss 5, p 1295 (2022)
In this position paper the Société Francophone d’OncoGériatrie (SOFOG; French-speaking oncogeriatric society), the Société Française de Pharmacie Oncologique (SFPO, French society for oncology pharmacy), the Groupe d’Investigateurs Nationau
Externí odkaz:
https://doaj.org/article/af95f3be969443af9657770847e0f44b
Autor:
Julie Niogret, Valentin Derangère, Corentin Richard, Lisa Nuttin, François Ghiringhelli, Laure Favier, Leila Bengrine Lefevre, Anthony Bergeron, Laurent Arnould, Romain Boidot
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 6, p 3343 (2022)
Low-grade serous carcinoma represents a minority of serous carcinoma. Although they have better prognosis than high-grade serous carcinoma, they respond poorly to chemotherapy. Thus, it appears necessary to find other treatments such as targeted ther
Externí odkaz:
https://doaj.org/article/6d89e60ecad64824b65caff06e33d1fb
Autor:
Valérie Jooste, Leila Bengrine-Lefevre, Sylvain Manfredi, Valérie Quipourt, Pascale Grosclaude, Olivier Facy, Côme Lepage, François Ghiringhelli, Anne-Marie Bouvier
Publikováno v:
Cancers, Vol 14, Iss 7, p 1675 (2022)
Background: Our objective was to describe real-world patterns of care and outcomes in pancreatic cancer. Methods: 912 patients diagnosed with pancreatic cancer from 2014 to 2017 were registered by the population-based cancer registry of Burgundy (Fra
Externí odkaz:
https://doaj.org/article/7a85172d03544e82becfbc2720c0c915